logo
  

Neurocrine Biosciences Inc Q2 Earnings Summary

Below are the earnings highlights for Neurocrine Biosciences Inc (NBIX):

Earnings: -$16.9 million in Q2 vs. $42.3 million in the same period last year.
EPS: -$0.18 in Q2 vs. $0.43 in the same period last year.
Excluding items, Neurocrine Biosciences Inc reported adjusted earnings of $82.1 million or $0.84 per share for the period.

Analysts projected $0.59 per share
Revenue: $378.2 million in Q2 vs. $288.9 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT